Correlation between immune-related adverse events and prognosis in patients with various cancers treated with anti PD-1 antibody

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1471-2407
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
Correlation between immune-related adverse events and prognosis in patients with various cancers treated with anti PD-1 antibody ; volume:20 ; number:1 ; day:14 ; month:7 ; year:2020 ; pages:1-8 ; date:12.2020
BMC cancer ; 20, Heft 1 (14.7.2020), 1-8, 12.2020

Urheber
Matsuoka, Hiroshi
Hayashi, Takahiro
Takigami, Karen
Imaizumi, Kazuyoshi
Shiroki, Ryoichi
Ohmiya, Naoki
Sugiura, Kazumitsu
Kawada, Kenji
Sawaki, Akira
Maeda, Koutaro
Ando, Yousuke
Uyama, Ichiro
Beteiligte Personen und Organisationen
SpringerLink (Online service)

DOI
10.1186/s12885-020-07142-3
URN
urn:nbn:de:101:1-2020091021540723376234
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
14.08.2025, 10:48 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Matsuoka, Hiroshi
  • Hayashi, Takahiro
  • Takigami, Karen
  • Imaizumi, Kazuyoshi
  • Shiroki, Ryoichi
  • Ohmiya, Naoki
  • Sugiura, Kazumitsu
  • Kawada, Kenji
  • Sawaki, Akira
  • Maeda, Koutaro
  • Ando, Yousuke
  • Uyama, Ichiro
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Editorial: Immune-Related Adverse Events for Patients With Lung Cancer

Editorial: Immune-Related Adverse Events for Patients With Lung Cancer

Managing immune-related adverse events in oncology

Managing immune-related adverse events in oncology

Unchecked immunity: a unique case of sequential immune-related adverse events with Pembrolizumab

Unchecked immunity: a unique case of sequential immune-related adverse events with Pembrolizumab

Neurologic immune-related adverse events associated with adjuvant ipilimumab: report of two cases

Neurologic immune-related adverse events associated with adjuvant ipilimumab: report of two cases

Correlation between immune-related adverse events and prognosis in patients with gastric cancer treated with nivolumab

Correlation between immune-related adverse events and prognosis in patients with gastric cancer treated with nivolumab

Association of immune-related adverse events with immune checkpoint inhibitor efficacy: real or imaginary?

Association of immune-related adverse events with immune checkpoint inhibitor efficacy: real or imaginary?

Concurrent therapy with immune checkpoint inhibitors and TNFα blockade in patients with gastrointestinal immune-related adverse events

Concurrent therapy with immune checkpoint inhibitors and TNFα blockade in patients with gastrointestinal immune-related adverse events

Corticosteroid-resistant immune-related adverse events: a systematic review

Corticosteroid-resistant immune-related adverse events: a systematic review

Co-administered antibody improves penetration of antibody–dye conjugate into human cancers with implications for antibody–drug conjugates

Co-administered antibody improves penetration of antibody–dye conjugate into human cancers with implications for antibody–drug conjugates

Immune-related serious adverse events with immune checkpoint inhibitors: Systematic review and network meta-analysis

Immune-related serious adverse events with immune checkpoint inhibitors: Systematic review and network meta-analysis

Predictive biomarkers for immune-related adverse events in cancer patients treated with immune-checkpoint inhibitors

Predictive biomarkers for immune-related adverse events in cancer patients treated with immune-checkpoint inhibitors

Immune-related adverse events with immune checkpoint inhibitors affecting the skeleton: a seminal case series

Immune-related adverse events with immune checkpoint inhibitors affecting the skeleton: a seminal case series

Verbundene Objekte